Notice2025-19256
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 2, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 189 (Thursday, October 2, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 189 (Thursday, October 2, 2025)]
[Notices]
[Pages 47764-47765]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-19256]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-0978]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Emerging Infections Program (EIP)'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on July 14, 2025, to obtain
comments from the public and affected agencies. CDC received no
comments. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Emerging Infections Program (OMB Control No. 0920-0978, Exp. 9/30/
2027)--Revision--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases.
Activities of the EIPs fall into the following general categories:
(1) active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies. Activities of the EIPs are designed to: (1) address
issues that the EIP network is particularly suited to investigate; (2)
maintain sufficient flexibility for emergency response and new problems
as they arise; (3) develop and evaluate public health interventions to
inform public health policy and treatment guidelines; (4) incorporate
training as a key function; and (5) prioritize projects that lead
directly to the prevention of disease.
Activities in the EIP Network to which all applicants must
participate are:
<bullet> Active Bacterial Core surveillance (ABCs): active
population-based laboratory surveillance for invasive bacterial
diseases.
<bullet> Foodborne Diseases Active Surveillance Network (FoodNet):
active population-based laboratory surveillance to monitor the
incidence of select enteric diseases.
<bullet> Influenza: active population-based surveillance for
laboratory confirmed influenza-related hospitalizations.
<bullet> Healthcare-Associated Infections-Community Interface
(HAIC) surveillance: active population-based surveillance for
healthcare-associated pathogens and infections.
A Revision is being submitted to make existing collection
instruments clearer and to add a new form specifically surveying
laboratory practices. This form will allow the EIP to better detect,
identify, track changes in laboratory testing methodology, gather
information about laboratory utilization in the EIP catchment area to
ensure that all cases are being captured, and survey EIP staff to
evaluate program quality.
CDC requests OMB approval for an estimated 40,733 annual burden
hours. There is no cost to respondents other than their time.
[[Page 47765]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form No. Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department...... ABC.100.1......... ABCs Case 10 984 20/60
Report Form.
ABC.100.2......... ABCs Invasive 10 127 10/60
Pneumococcal
Disease in
Children and
Adults Case
Report Form.
ABC.100.5......... ABCs Neonatal 10 37 20/60
Infection
Expanded
Tracking Form.
FN.200.1.......... FoodNet 10 550 21/60
Campylobacter.
FN.200.2.......... FoodNet 10 42 10/60
Cyclospora.
FN.200.3.......... FoodNet 10 16 20/60
Listeria
monocytogenes.
FN.200.4.......... FoodNet 10 855 21/60
Salmonella.
FN.200.5.......... FoodNet Shiga 10 290 20/60
toxin
producing E.
coli.
FN.200.6.......... FoodNet 10 234 10/60
Shigella.
FN.200.7.......... FoodNet Vibrio. 10 46 10/60
FN.200.8.......... FoodNet 10 55 10/60
Yersinia.
FN.200.9.......... FoodNet 10 10 1
Hemolytic
Uremic
Syndrome.
FN.200.10......... FoodNet 10 70 10/60
Clinical
Laboratory
Practices and
Testing Volume.
FSN.300.1......... FluSurv-Net 15 576 25/60
Influenza
Hospitalizatio
n Surveillance
Network Case
Report Form.
FSN.300.2......... FluSurv-Net 13 16 10/60
Influenza
Hospitalizatio
n Surveillance
Project
Vaccination
Phone Script
and Consent
Form (English/
Spanish).
FSN.300.3......... FluSurv-Net 13 126 5/60
Influenza
Hospitalizatio
n Surveillance
Project
Provider
Vaccination
History Fax
Form (Children/
Adults) and
notification
letter.
FSN.300.4......... FluSurv-NET 15 16 10/60
Laboratory
Survey.
HAIC.400.1........ HAIC--Multi- 11 1581 29/60
site Gram-
Negative
Surveillance
Initiative
(MuGSI) Case
Report Form
(CRF).
HAIC.400.2........ HAIC MuGSI CA 10 10 30/60
CP--CRE Health
interview.
HAIC.400.3........ HAIC MuGSI 11 1 20/60
Supplemental
Surveillance
Officer Survey.
HAIC.400.4........ HAIC--Invasive 10 788 29/60
Staphylococcus
aureus
Infection Case
Report Form.
HAIC.400.5........ HAIC--Invasive 10 11 9/60
Staphylococcus
aureus
Laboratory
Survey.
HAIC.400.6........ HAIC--Invasive 10 1 11/60
Staphylococcus
aureus
Supplemental
Surveillance
Officers
Survey.
HAIC.400.7........ HAIC--CDI Case 10 1,650 38/60
Report and
Treatment Form.
HAIC.400.8........ HAIC--Annual 10 16 17/60
Survey of
Laboratory
Testing
Practices for
C. difficile
Infections.
HAIC.400.9........ HAIC--CDI 10 1 15/60
Annual
Surveillance
Officers
Survey.
HAIC.400.10....... HAIC--Emerging 10 45 5/60
Infections
Program C.
difficile
Surveillance
Nursing Home
Telephone
Survey (LTCF).
HAIC.400.11....... HAIC Candidemia 10 170 40/60
Case Report
Form.
HAIC.400.12....... HAIC--Laborator 10 20 14/60
y Testing
Practices for
Candidemia
Questionnaire.
HAIC.400.13....... HAIC Death 10 8 24
Ascertainment
Project.
HAIC.400.14....... HAIC MuGSI KPC 10 60 60/60
and NDM
treatment
collection
form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-19256 Filed 10-1-25; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on October 2, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.